Wockhardt Limited Share Price & Technical Analysis
WOCKPHARMA · ₹2,074 (+5.48%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹2,074
+5.48%
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH …
Price chart
Seasonality
Jun has 3 positive and 2 negative years (last 5 years shown)
-13% return in Jun, 27% avg return in past 3 year Jun month.
33% return in 2026, 65% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | 1% | -10% | 13% | 46% | -13% | – | – | – | – | – | – | 33% |
| 25 | 0% | -26% | 21% | -11% | 13% | 17% | -3% | -14% | 6% | -15% | -4% | 16% | 0% |
| 24 | 7% | 31% | -3% | -8% | -7% | 26% | 23% | 16% | -8% | 24% | 14% | 0% | 116% |
| 23 | -8% | -9% | -18% | 9% | -1% | 39% | 1% | -1% | -2% | -4% | 52% | 22% | 80% |
| 22 | -5% | -14% | -15% | 4% | -5% | -19% | 7% | 10% | 2% | -4% | 2% | -7% | -46% |
Monthly return % by calendar month · historical pattern, not a forecast
Bullish · Strong · Strong
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹319.49B
P/E ratio
149.75
52W high
₹2,422
52W low
₹1,087
Volume
73,66,199
Beta
0.77
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,732
Frequently asked questions
- What is Wockhardt Limited share price today?
- Wockhardt Limited (WOCKPHARMA) last traded around ₹2,074 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does WOCKPHARMA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for WOCKPHARMA. Download the app for real-time alerts.
- How can I analyze Wockhardt Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.